Tag Archive for: transplant

Synklino announces first patient dosed in Phase 1 trial of SYN002 for CMV prevention in kidney transplantation

/in

Study to evaluate the safety and exploratory efficacy of SYN002 in recipients of human cytomegalovirus (CMV) positive donor kidneys, and to monitor for viral reactivation over the six months following transplantation Investigator-sponsored Phase 1 trial underway at the Ajmera Transplant Centre, University Health Network (UHN), Toronto, a world-renowned transplant center, conducted by Professor Atul Humar […]

Read more

Hansa Biopharma Report First Quarter 2026 Financial Results

/in

· PDUFA target date set for December 19 by the FDA · Runway significantly extended Lund, Sweden, 23 April 2026. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), today announced its interim report January-March 2026. Read more…

Read more

New paper in Frontiers in Medicine reveals first reliable biomarker test for early kidney transplant rejection detection in living-donor recipients

/in

Use of numares’ metabolite constellation showed a stable urinary metabolic profile in the first 14 days for living donor recipients, enabling accurate early rejection detection Deceased donor recipients exhibit ischemia‑driven metabolic alterations that transiently mask rejection signals Groundbreaking study was led by researchers at University Hospital Regensburg in conjunction with numares Health Regensburg, Germany, 09 […]

Read more

Hansa hosts call with distinguished transplant surgeons: Insights on clinical practice and imlifidase Phase 3 Results

/in

Lund, Sweden, 29 October 2025. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA) today announced that it will host a virtual event featuring two distinguished transplant surgeons; Professor Robert Montgomery from NYU Langone Transplant Institute and Professor Matthew Cooper from the Medical College of Wisconsin, to provide deeper insights into the medical journey of highly sensitized […]

Read more
© Optimum Strategic Communications.